BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• 

  Executive Appointments

  Pfizer Shakes Up C-Suite, Elevating Cancer Chief Boshoff to CSO

  Chris Boshoff will take over as Pfizer’s next chief scientific officer as of January 1, replacing Mikael Dolsten who led the pharma through the COVID-19 pandemic. The move comes weeks after Pfizer faced pressure from activist investor Starboard Value.

  November 20, 2024

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles

  November 20, 2024

   · 

  5 min read
• Press Releases

  Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

  November 20, 2024

   · 

  6 min read
• Press Releases

  enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

  November 20, 2024

   · 

  7 min read
• Press Releases

  First Patient Dosed in Aptevo’s Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies

  November 20, 2024

   · 

  9 min read
• Press Releases

  Pivot Bio Names Jason Hoag Head of North American Commercial Distribution

  November 20, 2024

   · 

  2 min read
• Press Releases

  Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program

  November 20, 2024

   · 

  11 min read
• Press Releases

  Battelle Bringing Clarity to PFAS Picture

  November 20, 2024

   · 

  2 min read
• Press Releases

  Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity

  November 20, 2024

   · 

  5 min read
• Press Releases

  Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

  November 20, 2024

   · 

  5 min read